PAM-adjacent DNA flexibility tunes CRISPR-Cas12a off-target binding

Aleique Allen1, Brendon H Cooper2,3, Jaideep Singh1

  • 1Department of Chemistry, University of Southern California, 3430 S Vermont Ave., Los Angeles, CA, 90089, USA.

Scientific Reports
|February 10, 2025
PubMed

Insights

DNA flexibility near the protospacer-adjacent motif (PAM) influences Cas12a nuclease off-target binding. Unpairing at PAM+1, +2, and +3 positions increases Cas12a off-target activity, impacting genome editing applications.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Cas12a is a CRISPR-associated nuclease used for genome manipulation.
  • DNA flexibility adjacent to the protospacer-adjacent motif (PAM) is implicated in Cas12a target recognition.

Purpose of the Study:

  • To investigate the relationship between PAM-adjacent DNA flexibility and Cas12a off-target binding.
  • To understand how DNA sequence variations near the PAM affect Cas12a specificity.

Main Methods:

  • Adapted a SELEX-seq approach to analyze DNA-DNA mismatches at PAM+1 to +6 positions.
  • In vitro binding assays with FnCas12a were performed using a DNA library with mismatches.
  • Sequencing of bound and unbound DNA populations determined off-target binding propensity.

Main Results:

  • Cas12a off-target binding is dependent on PAM-adjacent DNA flexibility.
  • Unpairing of the protospacer at PAM+1 is required for off-target binding.
  • Off-target binding increases with unpairing at PAM+2 and +3 positions.

Conclusions:

  • PAM-adjacent DNA flexibility can modulate Cas12a off-target binding.
  • Physical properties of DNA influence Cas12a target discrimination.
  • Findings have implications for optimizing Cas12a-based genome editing tools.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.1K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.1K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.9K